Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 26781 - 26800 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L04AC07) tocilizumab (adm: P) | Actemra 80 mg/4 mL injection, 4 mL vial | Concentrate for injection 80 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Actemra 80 mg/4 mL injection, 4 mL vial | Concentrate for injection 80 mg in 4 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Actemra 80 mg/4 mL injection, 4 mL vial | Concentrate for injection 80 mg in 4 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Actemra 80 mg/4 mL injection, 4 mL vial | Concentrate for injection 80 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Actemra 80 mg/4 mL injection, 4 mL vial | Concentrate for injection 80 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Actemra 80 mg/4 mL injection, 4 mL vial | Concentrate for injection 80 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Actemra 80 mg/4 mL injection, 4 mL vial | Concentrate for injection 80 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Actemra 80 mg/4 mL injection, 4 mL vial | Concentrate for injection 80 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Actemra 80 mg/4 mL injection, 4 mL vial | Concentrate for injection 80 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Actemra 80 mg/4 mL injection, 4 mL vial | Concentrate for injection 80 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Actemra 80 mg/4 mL injection, 4 mL vial | Concentrate for injection 80 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | RocheProductsPtyLtd |
| Australia | (L04AC16) guselkumab (adm: P) | Tremfya 100 mg/mL injection, 1 mL pen device | Injection 100 mg in 1 mL single use pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis;Crohn Disease;Colitis, Ulcerative | Janssen-CilagPtyLtd |
| Australia | (L04AC16) guselkumab (adm: P) | Tremfya 100 mg/mL injection, 1 mL syringe | Injection 100 mg in 1 mL single use pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis;Crohn Disease;Colitis, Ulcerative | Janssen-CilagPtyLtd |
| Australia | (L04AC16) guselkumab (adm: P) | Tremfya 100 mg/mL injection, 1 mL syringe | Injection 100 mg in 1 mL single use pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis;Crohn Disease;Colitis, Ulcerative | Janssen-CilagPtyLtd |
| Australia | (M05BA07) risedronic acid (adm: O) | Risedronate (WGR) 35 mg tablet, 4 | Tablet containing risedronate sodium 35 mg, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | WAGNERPHARMACEUTICALSPTYLTD |
| Australia | (M05BA07) risedronic acid (adm: O) | Risedronate (WGR) 35 mg tablet, 4 | Tablet containing risedronate sodium 35 mg, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | WAGNERPHARMACEUTICALSPTYLTD |
| Australia | (M05BX04) denosumab (adm: P) | Wyost 120 mg/1.7 mL injection, 1.7 mL vial | Injection 120 mg in 1.7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Giant Cell Tumor of Bone;Neoplasms, Bone Tissue | SandozPtyLtd |
| Australia | (M05BX04) denosumab (adm: P) | Wyost 120 mg/1.7 mL injection, 1.7 mL vial | Injection 120 mg in 1.7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Giant Cell Tumor of Bone;Neoplasms, Bone Tissue | SandozPtyLtd |
| Australia | (M05BX04) denosumab (adm: P) | Xgeva 120 mg/1.7 mL injection, 1.7 mL vial | Injection 120 mg in 1.7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Giant Cell Tumor of Bone;Neoplasms, Bone Tissue | AmgenAustraliaPtyLimited |
| Australia | (M05BX04) denosumab (adm: P) | Xgeva 120 mg/1.7 mL injection, 1.7 mL vial | Injection 120 mg in 1.7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Giant Cell Tumor of Bone;Neoplasms, Bone Tissue | AmgenAustraliaPtyLimited |
Pages
